Search

everythinglearnresearchcommunity

for

Search:↓

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

Prolactin may be important for skin growth and immune function.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.

The document concludes that understanding hair follicles requires more research using computational methods and an integrative approach, considering the current limitations in hair treatment products.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

COVID-19 may harm male fertility and damage the reproductive system.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Alternative treatments show promise for hair growth beyond traditional methods.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Various treatments exist for hair loss, but more research is needed for better options.

Eating selenium-rich rice improved antioxidant activity and signs of aging in mice.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Calcipotriol treatment for scalp psoriasis does not cause hair loss.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.